Works matching IS 14764598 AND DT 2023 AND VI 22 AND IP 1
Results: 211
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01886-9
- By:
- Publication type:
- Article
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01903-x
- By:
- Publication type:
- Article
Dynamic altruistic cooperation within breast tumors.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01896-7
- By:
- Publication type:
- Article
Extracellular vesicles remodel tumor environment for cancer immunotherapy.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01898-5
- By:
- Publication type:
- Article
A positive feedback circuit driven by m<sup>6</sup>A-modified circular RNA facilitates colorectal cancer liver metastasis.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01848-1
- By:
- Publication type:
- Article
Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01893-w
- By:
- Publication type:
- Article
Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01900-0
- By:
- Publication type:
- Article
A liquid biopsy signature of circulating extracellular vesicles-derived RNAs predicts response to first line chemotherapy in patients with metastatic colorectal cancer.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01875-y
- By:
- Publication type:
- Article
Effects of RNA methylation on Tumor angiogenesis and cancer progression.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01879-8
- By:
- Publication type:
- Article
Significant CircRNAs in liver cancer stem cell exosomes: mediator of malignant propagation in liver cancer?
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01891-y
- By:
- Publication type:
- Article
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01907-7
- By:
- Publication type:
- Article
hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01887-8
- By:
- Publication type:
- Article
Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01899-4
- By:
- Publication type:
- Article
A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01908-6
- By:
- Publication type:
- Article
The University of Kansas Cancer Center (KUCC), an NCI designated comprehensive cancer center.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01902-y
- By:
- Publication type:
- Article
Exploiting innate immunity for cancer immunotherapy.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01885-w
- By:
- Publication type:
- Article
CDK5: an oncogene or an anti-oncogene: location location location.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01895-8
- By:
- Publication type:
- Article
The strategies to cure cancer patients by eradicating cancer stem-like cells.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01867-y
- By:
- Publication type:
- Article
Efficacy of cell-free DNA methylation-based blood test for colorectal cancer screening in high-risk population: a prospective cohort study.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01866-z
- By:
- Publication type:
- Article
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01841-8
- By:
- Publication type:
- Article
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01827-6
- By:
- Publication type:
- Article
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01897-6
- By:
- Publication type:
- Article
ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01871-2
- By:
- Publication type:
- Article
Outsmarting trogocytosis to boost CAR NK/T cell therapy.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01894-9
- By:
- Publication type:
- Article
A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01884-x
- By:
- Publication type:
- Article
Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01880-1
- By:
- Publication type:
- Article
Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01889-6
- By:
- Publication type:
- Article
CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01888-7
- By:
- Publication type:
- Article
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01864-1
- By:
- Publication type:
- Article
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01837-4
- By:
- Publication type:
- Article
Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01878-9
- By:
- Publication type:
- Article
Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01882-z
- By:
- Publication type:
- Article
Correction: CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01877-w
- By:
- Publication type:
- Article
The strategies to cure cancer patients by eradicating cancer stem-like cells.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01867-y
- By:
- Publication type:
- Article
Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01876-x
- By:
- Publication type:
- Article
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01865-0
- By:
- Publication type:
- Article
Retraction Note: m<sup>6</sup>A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01872-1
- By:
- Publication type:
- Article
Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01870-3
- By:
- Publication type:
- Article
ERK mediates interferon gamma-induced melanoma cell death.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01868-x
- By:
- Publication type:
- Article
Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01854-3
- By:
- Publication type:
- Article
LINC00922 decoys SIRT3 to facilitate the metastasis of colorectal cancer through up-regulation the H3K27 crotonylation of ETS1 promoter.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01859-y
- By:
- Publication type:
- Article
Profiling small RNAs in fecal immunochemical tests: is it possible?
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01869-w
- By:
- Publication type:
- Article
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01863-2
- By:
- Publication type:
- Article
Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01849-0
- By:
- Publication type:
- Article
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01860-5
- By:
- Publication type:
- Article
EYA4 promotes breast cancer progression and metastasis through its role in replication stress avoidance.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01861-4
- By:
- Publication type:
- Article
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01827-6
- By:
- Publication type:
- Article